Trans Oral Robotic Surgery
TORS was developed by Dr Gregory Weinstein and Dr. Bert O’Malley in 2004 at the University of Pennsylvania School of Medicine (PENN) and approved by the U.S. Food and Drug Administration (FDA) in 2009.
During TORS, the surgeon uses a sophisticated, computer – enhanced system which displays a magnified,
3 – D view of the surgical area that enables him to visualize the procedure in much greater detail than in a traditional surgery. TORS gives the surgeon an enhanced view of the cancer and surrounding tissue. Using a robotic system to guide the surgical tools, allows for more-precise movements in narrow spaces and the capability to work around corners. This result in preservation of maximum amount of healthy muscular and neurovascular tissue which helps the patient swallow on their own sooner and discharged home earlier.
TORS has dramatically improved the way doctors treat head and neck cancer patients, completely removing tumors while preserving speech, swallowing, and resulting in a quicker recovery.
Trans Oral Robotic Surgery may be used to treat:
- Throat cancer
- Tongue cancer
- Tonsil cancer
- Obstructive Sleep Apnea
Our Chairman Dr Pratap C Reddy has always believed in offering the best of care that is also most affordable. In keeping with this promise, Trans Oral Robotic Surgery is well within the range of people suffering from head and neck cancers and obstructive sleep apnea.
UPDATED ON 15/11/2023